| 英文别名 |
VX770;Ivacaftor (VX-770);N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide;Ivacaftor;N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide;VX-770;[14C]-Ivacaftor;N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxaraide;UNII-1Y740ILL1Z;VX770,VX 770,Ivacaftor;N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide (ACI);Kalydeco;N-(5-Hydroxy-2,4-di-tert-butylphenyl)-4-oxo-1H-quinoline-3-carboxamide;N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide;N-[2,4-Di(tert-butyl)-5-hydroxyphenyl]-4-oxo-1H,4H-quinoline-3-carboxamide;VX 770;IVACAFTOR [INN];N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide;Cystic Fibrosis Transmembrane Conductance Regulator Potentiator;CS-0497;CCG-268562;SMR004702900;MFCD17171361;GTPL4342;N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide;CHEMBL2010601;1Y740ILL1Z;EX-7211;DA-54489;BCP9000799;DTXCID00158772;TRIKAFTA COMPONENT IVACAFTOR;IVACAFTOR COMPONENT OF ORKAMBI;NS00009974;CTP-656; CTP-656; CTP-656; d9-ivacaftor;VX-561;VX-770, Ivacaftor, Kalydeco;SCHEMBL351373;EN300-7400944;IVACAFTOR [MI];D09916;HMS3744K05;C24H28N2O3;3-Quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-;CHEBI:66901;1134822-00-6;BCP19794;NCGC00242480-03;IVACAFTOR [ORANGE BOOK];R07AX02;Q6095693;IVACAFTOR COMPONENT OF TRIKAFTA;SYMKEVI COMPONENT IVACAFTOR;BDBM50032693;873054-44-5;ORKAMBI COMPONENT IVACAFTOR;VX7;AC-28324;DB08820;s1144;Ivacaftor [USAN];SB16815;DTXSID00236281;HMS3654E10;IVACAFTOR [WHO-DD];Ivacaftor (USAN/INN);MLS006011119;BCPP000199;N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;ivacaftorum;SW219620-1;Ivacaftor-d18;AKOS032950001;Z2146566713;1413431-05-6;IVACAFTOR [VANDF];EX-A441;Ivacaftor [USAN:INN];HY-13017;N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;BRD-K52818472-001-02-2;Kalydeco (TN);PURKAOJPTOLRMP-UHFFFAOYSA-N;NCGC00242480-01;AB01565806_02;N-(5-Hydroxy-2,4-bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide;AKOS015994762;SY067891;LE-0002 |